INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2024

A review compares contemporary bariatric metabolic surgery and novel incretin mimetic therapies for managing obesity.

This review evaluates the advantages and disadvantages of modern pharmacologic and surgical weight management strategies for obesity. It examines data on anticipated weight loss, glycemic control, cardiometabolic improvements, and possible adverse outcomes associated with incretin-based drugs and bariatric metabolic surgery. The authors note that while lifestyle changes provide health benefits, weight loss from lifestyle alone is modest and hard to sustain.

Study type
Narrative review
Who was studied
Patients with obesity
What was measured
Weight loss, glycemic control, cardiometabolic benefits, and adverse effects

THE PAPER

Contemporary Management of Obesity: A Comparison of Bariatric Metabolic Surgery and Novel Incretin Mimetic Drugs.

Singh A, Nissen SE. Diabetes Technol Ther, 2024.

PubMed 38669473 ↗DOI 10.1089/dia.2024.0122 ↗

Heart & arteriesDiabetes & blood sugarWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.